FI116884B - Förfarande för framställning av en oftalmologisk lösning baserad på diklofenak och tobramycin - Google Patents

Förfarande för framställning av en oftalmologisk lösning baserad på diklofenak och tobramycin Download PDF

Info

Publication number
FI116884B
FI116884B FI960232A FI960232A FI116884B FI 116884 B FI116884 B FI 116884B FI 960232 A FI960232 A FI 960232A FI 960232 A FI960232 A FI 960232A FI 116884 B FI116884 B FI 116884B
Authority
FI
Finland
Prior art keywords
tobramycin
diclofenac
process according
pharmaceutically acceptable
isomer
Prior art date
Application number
FI960232A
Other languages
English (en)
Finnish (fi)
Other versions
FI960232A (sv
FI960232A0 (sv
Inventor
Cabrera Antonio Lopez
Cabello Gemma Torrella
Mas Jose Alberto Vallet
Michael Van Wie Bergamini
Original Assignee
Cusi Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cusi Lab filed Critical Cusi Lab
Publication of FI960232A0 publication Critical patent/FI960232A0/sv
Publication of FI960232A publication Critical patent/FI960232A/sv
Application granted granted Critical
Publication of FI116884B publication Critical patent/FI116884B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (13)

1. Förfarande för beredning av en oftalmologisk lösning, baserad :w och tobramycin, för lokalbehandling av ögon och öron, med ett pH 9, varvid den färdigberedda lösningen respektive en färdig hydrt • * * 1./ 25 följande, där procentandelarna avser massa/volym respektive mass *··;’ - 0,001-14 % räknat som diklofenak, tillsatt i form av diklofenak se * * * isomer av diklofenak eller ett derivat av nägon av de farmaceutis v : salterna av diklofenak; - 0,001-0,45 % räknat som tobramycin, tillsatt i form av tobramycii m s.j.i 30 en isomer av tobramycin eller ett derivat av nägon av de farmace - 0,001-0,45 % räknat som tobramycin, tillsatt i form av tobramycin tobramycin eller ett derivat av nägon av de farmaceutiskt godtagba tobramycin; samt - 3,0-7,0 % av en emulgator, vald ur gruppen bestäende av 5 glycerol-polyetylenglykol-fettsyraestrar och blandningar av dessa, s< att justera pH tili ett värde mellan 7 och 9.
2. Förfarande enligt patentkrav 1, kännetecknat av att det oc steget att tillsätta 0,4-7,5 % av ett medel för anpassning av isotonici 10
3. Förfarande enligt patentkrav 2, kännetecknat av att medlet f av isotoniciteten valts ur gruppen bestäende av natriumklorid, glycerol, mannitol och sorbitol. 15 4. Förfarande enligt patentkrav 1, kännetecknat av att det oc steget att tillsätta 0,01 -3,0 % av ett medel för buffring av pH-värdet.
5. Förfarande enligt patentkrav 4, kännetecknat av att medlet pH valts ur gruppen bestäende av acetater, citrater, borater, fosfate 20 metyl)aminometan samt aminosyror, exempelvis glycin, lysin, arginin och asparaginsyra. • » • · · :v; 6. Förfarande enligt patentkrav 1, kännetecknat av att det oc !·/: steget att tillsätta 0,01 -10,0 % av ett medel för justering av viskosite 25
7. Förfarande enligt patentkrav 6, kännetecknat av att medlet f< • · » *l\l viskositeten valts ur gruppen bestäende av polyvinylalkohol, polyv *·· ? metylcellulosa, hydroxipropylcellulosa, hydroxietylcellulosa, karboxi och hydroxipropylmetylcellulosa. φ so : : 8. Förfarande enlint natentkrav 1. kännetecknat av att det ne.
10. Förfarande enligt patentkrav 1, kännetecknat av att det ä steget att tillsätta 0,0005-0,015 % av ett konserveringsmedel i kvarternära ammoniumföreningar. 5 11. Förfarande enligt patentkrav 1, kännetecknat av att det ä steget att tillsätta 0,0005-0,015 % av ett konserveringsmedel ur gru silverföreningar.
12. Förfarande enligt patentkrav 1, kännetecknat av att det ä 10 steget att tillsätta 0,0005-0,015 % av ett konserveringsmedel v£ bestäende av kvarternära ammoniumföreningar, bensalkoniumkloi ammoniumbromid, cetylpyridinklorid, bensetonklorid, timerosal, fe acetat, fenylkvicksilvernitrat och blandningar av dessa. 15 13. Förfarande enligt patentkrav 1, kännetecknat av att det ä steget att tillsätta 0,05-0,5 % av ett konserveringsmedel ur gruppen propyl-p-hydroxibensoater och deras natriumsalter.
14. Förfarande enligt patentkrav 1, kännetecknat av att det ä 20 steget att tillsätta 0,05-0,75 % av fenyletylalkohol eller betafenylel konserveringsmedel. i « • i * i • · :v. 15. Förfarande enligt patentkrav 1, kännetecknat av att det ä ;\j steget att tillsätta 0,05-5,0 % av bensylalkohol som konserveringsm 25 * *
16. Förfarande enligt patentkrav 1, kännetecknat av att det ä steget att tillsätta 0,05-1,0 % av fenoxietanol som konserveringsmei • · · m
17. Förfarande enligt patentkrav 1, kännetecknat av att det ä « · : 30 steget att tillsätta 0,01-25 % av ett hjälpämne för bildning av en : : hvdroael.
FI960232A 1994-05-17 1996-01-17 Förfarande för framställning av en oftalmologisk lösning baserad på diklofenak och tobramycin FI116884B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ES09401078A ES2079320B1 (es) 1994-05-17 1994-05-17 Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones.
ES9401078 1994-05-17
ES9400084 1994-09-07
PCT/ES1994/000084 WO1995031179A1 (es) 1994-05-17 1994-09-07 Disolucion oftalmica a base de diclofenaco y tobramicina y sus aplicaciones

Publications (3)

Publication Number Publication Date
FI960232A0 FI960232A0 (sv) 1996-01-17
FI960232A FI960232A (sv) 1996-03-15
FI116884B true FI116884B (sv) 2006-03-31

Family

ID=8286285

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960232A FI116884B (sv) 1994-05-17 1996-01-17 Förfarande för framställning av en oftalmologisk lösning baserad på diklofenak och tobramycin

Country Status (21)

Country Link
US (1) US5597560A (sv)
EP (1) EP0711546B1 (sv)
KR (1) KR100353377B1 (sv)
CN (1) CN1098678C (sv)
AT (1) ATE198417T1 (sv)
AU (1) AU696853B2 (sv)
BG (1) BG100289A (sv)
BR (1) BR9407330A (sv)
CA (1) CA2167383C (sv)
DE (1) DE69426529T2 (sv)
DK (1) DK0711546T3 (sv)
ES (1) ES2079320B1 (sv)
FI (1) FI116884B (sv)
GR (1) GR3035633T3 (sv)
HK (1) HK1017806A1 (sv)
HU (1) HUT74164A (sv)
NO (1) NO308645B1 (sv)
OA (1) OA10570A (sv)
PL (1) PL312615A1 (sv)
PT (1) PT711546E (sv)
WO (1) WO1995031179A1 (sv)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19729879C2 (de) 1997-07-11 1999-07-08 Mann Gerhard Chem Pharm Fab Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US8173164B2 (en) * 1999-06-17 2012-05-08 Gruenenthal Gmbh Oral administration forms for administering a fixed tramadol and diclofenac combination
US20020061281A1 (en) * 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
YU4602A (sh) 1999-07-22 2005-06-10 Aventis Pharmaceuticals Inc. Farmaceutske formulacije zaštićene od dejstva mikroorganizama
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US20030139382A1 (en) * 2001-09-21 2003-07-24 Alcon, Inc. Method of treating middle ear infections
US7928147B2 (en) * 2002-04-11 2011-04-19 Teva Animal Health, Inc. Antimicrobial wash and carrier solutions, and uses thereof
US7727549B2 (en) * 2002-07-15 2010-06-01 Alcon, Inc. Pharmaceutical compositions for otic use
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9211259B2 (en) * 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US8486376B2 (en) * 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US7700076B2 (en) * 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9265725B2 (en) * 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20070292359A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
EP1556009B2 (en) 2002-10-25 2021-07-21 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7704518B2 (en) * 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20070292461A1 (en) * 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
WO2004056357A1 (en) * 2002-12-20 2004-07-08 Deepak Bahri Composition comprising diclofenac for treating otic pain and inflammation
DE122011100019I1 (de) 2003-01-21 2011-11-03 Senju Pharma Co Wassrige flussige zubereitung mit 2-amino-3-(4-bromobenzoyl) phenylessigsaure.
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
EP1481804A1 (en) 2003-05-28 2004-12-01 F.Hoffmann-La Roche Ag A device for dispensing drops of a liquid
AU2004261063A1 (en) * 2003-08-04 2005-02-10 Foamix Ltd. Foam carrier containing amphiphilic copolymeric gelling agent
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US20080069779A1 (en) * 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
CA2776692C (en) * 2003-08-25 2014-12-30 Foamix Ltd. Penetrating pharmaceutical foam
WO2005027977A2 (en) * 2003-09-22 2005-03-31 Agis Industries (1983) Ltd. Diclofenac compositions for the treatment of skin disorders
WO2005046700A1 (ja) 2003-11-14 2005-05-26 Senju Pharmaceutical Co., Ltd. アミノグリコシド系抗生物質およびブロムフェナクを含有する水溶液製剤
US8367086B1 (en) * 2004-02-02 2013-02-05 S.S. Steiner, Inc. Process and product for inhibiting or preventing bacterial infections
US20050186147A1 (en) * 2004-02-04 2005-08-25 Foamix Ltd. Cosmetic and pharmaceutical foam with solid matter
US20050214382A1 (en) * 2004-03-29 2005-09-29 Erning Xia Zinc preservative composition and method of use
JP2005310310A (ja) * 2004-04-23 2005-11-04 Sanyo Electric Co Ltd トラッキングバランス調整装置
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
US20060073173A1 (en) * 2004-10-04 2006-04-06 Maria Banach Large-scale manufacturing process for the production of pharmaceutical compositions
WO2007070801A2 (en) * 2005-12-12 2007-06-21 Allaccem, Inc. Methods and systems for preparing antimicrobial films and coatings
CN1981869B (zh) * 2005-12-14 2011-04-06 信谊药厂 含普拉洛芬的复方非载体抗菌眼用制剂及其制备方法
EP2049112B1 (en) * 2006-08-07 2012-03-14 Bausch & Lomb Incorporated Treating infections and sequelae thereof with combined dissociated glucocorticoid receptor agonists and anti-infective agents
MX2009002536A (es) * 2006-09-08 2009-04-14 Foamix Ltd Composicion espumable coloreada o coloreable y espuma.
AU2007356328A1 (en) * 2006-11-14 2009-01-15 Tal Berman Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
WO2008085913A1 (en) * 2007-01-04 2008-07-17 Rib-X Pharmaceuticals, Inc. Methods for treating, preventing, or reducing the risk of opthalmic, otic, and nasal infections
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
CA2683383C (en) 2007-02-21 2016-01-05 Allaccem, Incorporated Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
PL1986473T3 (pl) * 2007-04-03 2017-07-31 Tsinghua University Organiczne urządzenie elektroluminescencyjne
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US8188068B2 (en) * 2007-08-10 2012-05-29 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in pets
US8153618B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for topical applications for pets
US8153617B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in humans
US20090074833A1 (en) * 2007-08-17 2009-03-19 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling bone resorption
US20090130029A1 (en) * 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
AU2009205314A1 (en) * 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US20100004218A1 (en) * 2008-06-20 2010-01-07 Whiteford Jeffery A Bridged polycyclic compound based compositions for renal therapy
US20100016270A1 (en) * 2008-06-20 2010-01-21 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling cholesterol levels
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
AU2010302350B2 (en) 2009-10-02 2015-06-18 Journey Medical Corporation Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
JP5864429B2 (ja) 2009-11-09 2016-02-17 スポットライト テクノロジー パートナーズ エルエルシーSpotlight Technology Partners Llc 架橋ヒドロゲル組成物、ヒドロゲル組成物の形成方法、及びキット
WO2011057133A1 (en) 2009-11-09 2011-05-12 Spotlight Technology Partners Llc Fragmented hydrogels
CN102526738B (zh) * 2010-12-27 2016-03-30 沈阳兴齐眼药股份有限公司 一种复方眼用制剂、其制备方法和用途
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
CN107865966A (zh) * 2016-09-23 2018-04-03 刘力 局部给药的复方氨基糖苷类药物组合物
KR102283681B1 (ko) * 2020-01-17 2021-07-29 조선대학교 산학협력단 렌즈 형상의 약물 전달 시스템 및 이의 제조 방법
EP4112041A1 (en) * 2021-06-30 2023-01-04 GSK Consumer Healthcare SARL Micellar solution comprising diclofenac

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087538A (en) * 1976-09-09 1978-05-02 Merck & Co., Inc. Ophthalmic suspensions
US4407792A (en) * 1979-05-09 1983-10-04 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
NZ196700A (en) * 1980-04-18 1983-04-12 Smith & Nephew Ass Anti-inflammatory compositions containing 5-benzoyl-1-methylpyrrole-2-acetic acid derivatives
US4478822A (en) * 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4668506A (en) * 1985-08-16 1987-05-26 Bausch & Lomb Incorporated Sustained-release formulation containing and amino acid polymer
DE3612537C1 (de) * 1986-04-14 1987-07-16 Dispersa Ag Arzneimittel zur Behandlung von Entzuendungen im Auge
US5414011A (en) * 1987-09-11 1995-05-09 Syntex (U.S.A.) Inc. Preservative system for ophthalmic formulations
KR950013754B1 (ko) * 1987-09-11 1995-11-15 신텍스(미합중국)인코포레이티드 안과용 비스테로이드계 소염제제
AU606515B2 (en) * 1988-03-09 1991-02-07 Alcon Laboratories, Inc. Combination of tobramycin and steroids for topical ophthalmic use
ES2079994B1 (es) * 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.

Also Published As

Publication number Publication date
EP0711546A1 (en) 1996-05-15
DE69426529T2 (de) 2001-08-09
OA10570A (en) 2002-06-20
ATE198417T1 (de) 2001-01-15
AU696853B2 (en) 1998-09-17
NO960207L (no) 1996-03-15
FI960232A (sv) 1996-03-15
BG100289A (en) 1996-12-31
DK0711546T3 (da) 2001-04-23
US5597560A (en) 1997-01-28
HK1017806A1 (en) 1999-11-26
PL312615A1 (en) 1996-04-29
CN1130351A (zh) 1996-09-04
DE69426529D1 (de) 2001-02-08
PT711546E (pt) 2001-06-29
AU7616094A (en) 1995-12-05
BR9407330A (pt) 1996-06-18
EP0711546B1 (en) 2001-01-03
NO308645B1 (no) 2000-10-09
FI960232A0 (sv) 1996-01-17
CN1098678C (zh) 2003-01-15
KR960703581A (ko) 1996-08-31
KR100353377B1 (ko) 2002-12-26
HUT74164A (en) 1996-11-28
GR3035633T3 (en) 2001-06-29
CA2167383A1 (en) 1995-11-23
NO960207D0 (no) 1996-01-17
ES2079320B1 (es) 1996-10-16
CA2167383C (en) 2001-11-20
ES2079320A1 (es) 1996-01-01
WO1995031179A1 (es) 1995-11-23

Similar Documents

Publication Publication Date Title
FI116884B (sv) Förfarande för framställning av en oftalmologisk lösning baserad på diklofenak och tobramycin
CA2307632C (en) Aqueous liquid pharmaceutical composition
US20100003334A1 (en) Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
EP1782816B1 (en) Water-based medicinal composition containing azithromycin and method of preparing the same
EP0824916B1 (en) Pranoprofen eyedrops containing organic amine
EP2002841A1 (en) Ophthalmic composition comprising xanthan gum and glucose
KR101052705B1 (ko) 아미노글리코시드계 항생물질 및 브롬페낙을 함유하는수용액 제제
WO2003086332A1 (en) Antimicrobial wash and carrier solutions, and uses thereof
JPH11240838A (ja) アジスロマイシンによる眼感染症の治療法
JP6683622B2 (ja) 眼科用水性組成物
JP2020508349A (ja) 安定なペプチド組成物
JPH115744A (ja) ヒアルロン酸含有の外用水溶液製剤
WO2004069280A1 (en) Pharmaceutical inclusion complexes containing a steroid and optionally an antibacterial agent
AU2013344497B2 (en) Aqueous liquid composition containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
KR20100014858A (ko) 국소 비강 투여용 올로파타딘 제제
US20030109422A1 (en) Process for the preparation of pharmaceutical formulations containing lactoferrin
HUT59001A (en) Process for producing antimicrobial ophtalmological preparations
US10792271B2 (en) Topical formulations of chloroprocaine and methods of using same
JP2011225605A (ja) 点眼剤
CN109641059B (zh) 具有改善的防腐效力或光稳定性的眼科药物组合物
SA90110074B1 (ar) تركيبات صيدلانية متضمنة على محلول مائي من مشتق بيرانوكوينولين pyranoquinoline
US20020077358A1 (en) Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery
AU2018220172A1 (en) Triazole-containing macrolides and ophthalmic uses therefor
JPH06211659A (ja) 点鼻薬組成物
WO2007099431A2 (en) An aqueous liquid pharmaceutical compositions of gatifloxacin

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 116884

Country of ref document: FI